113 related articles for article (PubMed ID: 37287266)
1. Test sensitivity in a prospective cancer screening program: A critique of a common proxy measure.
Lange J; Zhao Y; Gogebakan KC; Olivas-Martinez A; Ryser MD; Gard CC; Etzioni R
Stat Methods Med Res; 2023 Jun; 32(6):1053-1063. PubMed ID: 37287266
[TBL] [Abstract][Full Text] [Related]
2. Modelling the overdiagnosis of breast cancer due to mammography screening in women aged 40 to 49 in the United Kingdom.
Gunsoy NB; Garcia-Closas M; Moss SM
Breast Cancer Res; 2012 Nov; 14(6):R152. PubMed ID: 23194032
[TBL] [Abstract][Full Text] [Related]
3. A simulation model investigating the impact of tumor volume doubling time and mammographic tumor detectability on screening outcomes in women aged 40-49 years.
Bailey SL; Sigal BM; Plevritis SK
J Natl Cancer Inst; 2010 Aug; 102(16):1263-71. PubMed ID: 20664027
[TBL] [Abstract][Full Text] [Related]
4. Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program.
Olsen AH; Agbaje OF; Myles JP; Lynge E; Duffy SW
Breast J; 2006; 12(4):338-42. PubMed ID: 16848843
[TBL] [Abstract][Full Text] [Related]
5. National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium.
Lehman CD; Arao RF; Sprague BL; Lee JM; Buist DS; Kerlikowske K; Henderson LM; Onega T; Tosteson AN; Rauscher GH; Miglioretti DL
Radiology; 2017 Apr; 283(1):49-58. PubMed ID: 27918707
[TBL] [Abstract][Full Text] [Related]
6. Interval breast cancers in the 'screening with tomosynthesis or standard mammography' (STORM) population-based trial.
Houssami N; Bernardi D; Caumo F; Brunelli S; Fantò C; Valentini M; Romanucci G; Gentilini MA; Zorzi M; Macaskill P
Breast; 2018 Apr; 38():150-153. PubMed ID: 29328943
[TBL] [Abstract][Full Text] [Related]
7. Breast screening using 2D-mammography or integrating digital breast tomosynthesis (3D-mammography) for single-reading or double-reading--evidence to guide future screening strategies.
Houssami N; Macaskill P; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Ciatto S
Eur J Cancer; 2014 Jul; 50(10):1799-1807. PubMed ID: 24746887
[TBL] [Abstract][Full Text] [Related]
8. Estimating the natural progression of non-invasive ductal carcinoma in situ breast cancer lesions using screening data.
Weedon-Fekjær H; Li X; Lee S
J Med Screen; 2021 Sep; 28(3):302-310. PubMed ID: 32854582
[TBL] [Abstract][Full Text] [Related]
9. National Performance Benchmarks for Modern Diagnostic Digital Mammography: Update from the Breast Cancer Surveillance Consortium.
Sprague BL; Arao RF; Miglioretti DL; Henderson LM; Buist DS; Onega T; Rauscher GH; Lee JM; Tosteson AN; Kerlikowske K; Lehman CD;
Radiology; 2017 Apr; 283(1):59-69. PubMed ID: 28244803
[TBL] [Abstract][Full Text] [Related]
10. Estimating mean sojourn time and screening test sensitivity in breast cancer mammography screening: new results.
Weedon-Fekjaer H; Vatten LJ; Aalen OO; Lindqvist B; Tretli S
J Med Screen; 2005; 12(4):172-8. PubMed ID: 16417693
[TBL] [Abstract][Full Text] [Related]
11. Estimating Age-Specific Mean Sojourn Time of Breast Cancer and Sensitivity of Mammographic Screening by Breast Density among Korean Women.
Choi E; Suh M; Jung SY; Jung KW; Park S; Jun JK; Choi KS
Cancer Res Treat; 2023 Jan; 55(1):136-144. PubMed ID: 35381162
[TBL] [Abstract][Full Text] [Related]
12. Estimation of natural history parameters of breast cancer based on non-randomized organized screening data: subsidiary analysis of effects of inter-screening interval, sensitivity, and attendance rate on reduction of advanced cancer.
Wu JC; Hakama M; Anttila A; Yen AM; Malila N; Sarkeala T; Auvinen A; Chiu SY; Chen HH
Breast Cancer Res Treat; 2010 Jul; 122(2):553-66. PubMed ID: 20054645
[TBL] [Abstract][Full Text] [Related]
13. Comparing sensitivity and specificity of screening mammography in the United States and Denmark.
Kemp Jacobsen K; O'Meara ES; Key D; S M Buist D; Kerlikowske K; Vejborg I; Sprague BL; Lynge E; von Euler-Chelpin M
Int J Cancer; 2015 Nov; 137(9):2198-207. PubMed ID: 25944711
[TBL] [Abstract][Full Text] [Related]
14. Effect of integrating digital breast tomosynthesis (3D-mammography) with acquired or synthetic 2D-mammography on radiologists' true-positive and false-positive detection in a population screening trial: A descriptive study.
Bernardi D; Li T; Pellegrini M; Macaskill P; Valentini M; Fantò C; Ostillio L; Houssami N
Eur J Radiol; 2018 Sep; 106():26-31. PubMed ID: 30150047
[TBL] [Abstract][Full Text] [Related]
15. One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study.
Zackrisson S; Lång K; Rosso A; Johnson K; Dustler M; Förnvik D; Förnvik H; Sartor H; Timberg P; Tingberg A; Andersson I
Lancet Oncol; 2018 Nov; 19(11):1493-1503. PubMed ID: 30322817
[TBL] [Abstract][Full Text] [Related]
16. Effect of integrating 3D-mammography (digital breast tomosynthesis) with 2D-mammography on radiologists' true-positive and false-positive detection in a population breast screening trial.
Bernardi D; Caumo F; Macaskill P; Ciatto S; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Houssami N
Eur J Cancer; 2014 May; 50(7):1232-8. PubMed ID: 24582915
[TBL] [Abstract][Full Text] [Related]
17. Estimating key parameters in periodic breast cancer screening-application to the Canadian National Breast Screening Study data.
Chen Y; Brock G; Wu D
Cancer Epidemiol; 2010 Aug; 34(4):429-33. PubMed ID: 20434974
[TBL] [Abstract][Full Text] [Related]
18. Interval breast cancers: absolute and proportional incidence and blinded review in a community mammographic screening program.
Carbonaro LA; Azzarone A; Paskeh BB; Brambilla G; Brunelli S; Calori A; Caumo F; Malerba P; Menicagli L; Sconfienza LM; Vadalà G; Brambilla G; Fantini L; Ciatto S; Sardanelli F
Eur J Radiol; 2014 Feb; 83(2):e84-91. PubMed ID: 24369953
[TBL] [Abstract][Full Text] [Related]
19. Association of Screening With Digital Breast Tomosynthesis vs Digital Mammography With Risk of Interval Invasive and Advanced Breast Cancer.
Kerlikowske K; Su YR; Sprague BL; Tosteson ANA; Buist DSM; Onega T; Henderson LM; Alsheik N; Bissell MCS; O'Meara ES; Lee CI; Miglioretti DL
JAMA; 2022 Jun; 327(22):2220-2230. PubMed ID: 35699706
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]